Profile data is unavailable for this security.
About the company
Deltex Medical Group Plc is a United Kingdom-based medical device company. The Company develops, manufactures and distributes a hemodynamic monitoring technology. The Company's TrueVue platform offers three monitoring technologies, such as Oesophageal Doppler Monitoring (ODM+), Pulse Pressure Waveform Analysis (PPWA) and High Definition Impedance CardioGraphy (HD-ICG). Its ODM+ is a fluid management and cardiac output monitoring technology to directly measure both flow and pressure in adults and pediatrics. HD-ICG provides continuous and sensitive measurements of cardiac output and other hemodynamic parameters. The system is stabilized using HD-Z signal filter technology. HD-ICG disposable electrodes are placed on the neck and chest. PPWA uses the researched pulse pressure wave algorithm, which is available to derive hemodynamic parameters, calibrated from the Doppler. Its applications include surgery, acute kidney injury, enhanced recovery, paediatric, and COVID-19 critical care.
- Revenue in GBP (TTM)1.78m
- Net income in GBP-1.28m
- Incorporated2000
- Employees37.00
- LocationDeltex Medical Group PLCTerminus RoadCHICHESTER PO19 8TXUnited KingdomGBR
- Phone+44 124 377 4837
- Fax+44 124 353 2534
- Websitehttps://www.deltexmedical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Image Scan Holdings Plc | 2.96m | 123.94k | 1.64m | 14.00 | 13.19 | 1.09 | 7.10 | 0.5543 | 0.0009 | 0.0009 | 0.0217 | 0.0111 | 1.22 | 3.13 | 4.66 | 211,637.90 | 5.12 | -1.15 | 7.77 | -1.77 | 48.44 | 51.36 | 4.18 | -1.01 | 2.03 | -- | 0.098 | -- | 47.98 | -3.08 | 145.65 | -- | 40.19 | -- |
| Truspine Technologies PLC | 0.00 | -471.89k | 2.24m | 1.00 | -- | 0.7821 | -- | -- | -0.004 | -0.004 | 0.00 | 0.0205 | 0.00 | -- | -- | 0.00 | -13.14 | -21.97 | -16.58 | -26.49 | -- | -- | -- | -- | -- | -32.31 | 0.0984 | -- | -- | -- | 23.29 | -- | 21.72 | -- |
| Deltex Medical Group plc | 1.78m | -1.28m | 2.56m | 37.00 | -- | 0.758 | -- | 1.44 | -0.0012 | -0.0012 | 0.0015 | 0.0018 | 0.2974 | 0.8471 | 5.61 | 48,000.00 | -21.47 | -14.66 | -29.13 | -21.81 | 63.34 | 71.84 | -72.18 | -32.93 | 1.13 | -2.98 | 0.3793 | -- | -28.44 | -18.55 | -11.97 | -- | 9.78 | -- |
| Surgical Innovations Group Plc | 12.01m | -509.00k | 4.67m | 90.00 | -- | 0.4449 | 18.84 | 0.389 | -0.0005 | -0.0005 | 0.0129 | 0.0112 | 0.8032 | 2.85 | 5.89 | -- | -3.40 | -8.19 | -4.18 | -9.94 | 28.70 | 32.51 | -4.24 | -13.31 | 1.23 | -4.45 | 0.1368 | -- | 5.94 | 1.84 | -292.80 | -- | 7.20 | -- |
| Myhealthchecked PLC | 14.95m | 189.00k | 5.20m | 15.00 | 26.95 | 0.6083 | 15.71 | 0.348 | 0.0037 | 0.0037 | 0.2885 | 0.1644 | 1.26 | 5.81 | 7.95 | 996,400.00 | 1.59 | -20.09 | 2.21 | -28.23 | 27.79 | 22.62 | 1.26 | -13.42 | 3.53 | -- | 0.0047 | -- | 36.26 | 190.36 | -24.30 | -- | -12.80 | -- |
| Rua Life Sciences PLC | 1.87m | -1.87m | 6.67m | 40.00 | -- | 0.6387 | -- | 3.57 | -0.0843 | -0.0843 | 0.0843 | 0.1683 | 0.3293 | 3.26 | 4.80 | 46,725.00 | -32.95 | -25.97 | -36.33 | -28.26 | 81.97 | -- | -100.05 | -110.53 | 2.40 | -61.71 | 0.1065 | -- | 34.09 | 40.08 | 3.10 | -- | 94.82 | -- |
| Advanced Oncotherapy PLC | 0.00 | -32.60m | 9.50m | 174.00 | -- | 0.1306 | -- | -- | -0.0819 | -0.0819 | 0.00 | 0.134 | 0.00 | 0.00 | -- | 0.00 | -23.34 | -25.83 | -29.05 | -30.15 | -- | -- | -- | -- | 0.1293 | -4.06 | 0.4968 | -- | -- | -- | -16.57 | -- | -0.8064 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Herald Investment Management Ltd.as of 25 Jan 2024 | 107.69m | 5.68% |
| Cantor Fitzgerald Europeas of 01 Apr 2024 | 45.19m | 2.38% |
| Janus Henderson Investors UK Ltd.as of 12 Feb 2019 | 32.47m | 1.71% |
| Winterflood Securities Ltd (Market-Maker)as of 01 Apr 2024 | 27.56m | 1.45% |
| Pilling & Co. Stockbrokers Ltd.as of 01 Apr 2024 | 24.24m | 1.28% |
| Evelyn Partners Investment Management LLPas of 01 Apr 2024 | 22.09m | 1.17% |
| Interactive Investor Services Ltd.as of 12 Feb 2019 | 21.68m | 1.14% |
| Hargreaves Lansdown Asset Management Ltd.as of 12 Feb 2019 | 21.53m | 1.14% |
| T. Rowe Price International Ltd.as of 04 Apr 2024 | 19.72m | 1.04% |
| Barclays Bank Plc (Private Banking)as of 12 Feb 2019 | 19.41m | 1.02% |
